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Background: Actinomycetes have provided a wealth of bioactive secondary metabolites with interesting activities such
as antimicrobial, antiviral and anticancer. The study aims at isolation, characterization and the antimicrobial potentiality of
Streptomyces sannanensis SU118 obtained from Phoomdi, a unique habitat of Loktak Lake of Manipur, India.
Results: An actinomycete strain isolated from Phoomdi soil of Loktak Lake of Manipur, India was identified as
Streptomyces sannanensis SU118. It is a Gram-positive filamentous bacterium which exhibits antimicrobial activity only
against Gram-positive bacteria, while Gram-negative organisms were not affected. Glucose Soyabean meal broth was
found to be the suitable medium for antibiotic production at 28°C for seven days of incubation. The antimicrobial agent
produced by the strain was extracted with ethyl acetate as solvent and purified by thin layer chromatography. Screening
and bioassay - guided fractionation of the ethyl acetate extract from the culture filtrate led to the isolation of an active
potential compound (Rf value 0.56) with λmax 275.0 nm which has got the lowest minimum inhibitory concentration
(0.5 μg/ml) against Staphylococcus aureus MTCC 96 and Staphylococcus aureus (clinical isolate), whereas highest (3.0 μg/ml)
was recorded against Mycobacterium smegmatis MTCC 6 and Bacillus circulans MTCC 8074.
Conclusion: This study has therefore uncovered the potential of exploring virgin untapped habitats in the Indo-Burma
biodiversity hot spot region as reservoir of promising antimicrobial metabolite producer. These results highlighted the
scope for further characterization of the metabolite and could be a candidate in the generation of new antimicrobial
agents.
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Microbial natural products are the origin of most of
the antibiotics on the market today. There is an
alarming scarcity of new antibiotics currently under
development in the pharmaceutical industry. Still,
microbial natural products remain the most promising
source of novel antibiotics, although new approaches
are required to improve the efficiency of the discovery
process. Actinomycetes have provided important bioactive
compounds of high commercial value and continue to be* Correspondence: shantiks@rediffmail.com
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unless otherwise stated.routinely screened for new bioactive substances [1,2]. It
is generally accepted that the streptomycetes have a
particular capacity to produce a large variety of different
bioactive compounds that have a wide spectrum of activity
[3]. It is reported that 45% of the presently known bioactive
microbial metabolites were still isolated from various
actinomycetales species, and the Streptomyces species
produces 7600 compounds (74% of all actinomycetales),
while the rare actinomycetes represent 26%, altogether
2500 compounds [4]. These organisms produce perhaps the
most diverse and most unique, unprecedented, sometimes
very complicated compounds exhibiting excellent
antimicrobial potency and usually low toxicity [4]. The
metabolic diversity of the actinomycetes is due to itstd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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tion factors that control gene expression, allowing them to
respond to specific needs [5]. Streptomyces sp. strain 201
endowed with novel antibiotic property has been isolated
from tea garden soil [6]. Antimicrobial potentiality of salt-
tolerant and alkaliphilic strain, Streptomyces tanashiensis
A2D has also been reported by Singh et al. [7]. A
new antiherpetic agent, fattiviracin has been isolated from
Streptomyces microflavus [8]. These recent examples from
the literature highlights the fact that despite extensive
exploration of the actinomycetes for their antimicrobial
products in the past, the search for novel molecules having
unique therapeutic properties continues to be an active
area of research. In the course of screening for new
antibiotics, several studies are oriented towards isolation
of new Streptomyces species from different habitats.
Although soils have been screened by many workers for the
past many decades, only a small fraction of actinomycetes
have been discovered [9]. Actinomycetes from unexplored
habitats have gained considerable attention in recent years
for the production of bioactive metabolites.
The expanding list of novel microorganisms and the
products derived from poorly explored areas of the world
like Jordan [10], Antarctica [11] and certain biotope of
Manipur [7] suggest that a careful exploration of new
habitats might continue to be useful. The isolation of
these microorganisms that produce bioactive compounds
is of great interest in the development of new molecules
to fight against many pathogen especially with the
emergence of antibiotic multi-resistant pathogens.
The present study is a part of our on-going and extensive
screening being carried out in the hitherto unexplored hab-
itats of North-East India, under Indo-Burma Biodiversity
hot spot with a view to realize the bioresources and value
they have to mankind. This communication deals with the
isolation, characterization and antimicrobial potentiality
of a new actinomycete strain identified as Streptomyces
sannanensis SU118.
Methods
Location and collection of soil sample
Soil samples were collected at a depth of 10–15 cm from
the upper surface of top soil from phoomdi in Loktak lake
(latitude, 240 25′ - 240 42′ N; longitude, 930 46′ - 930 55′ E)
of Manipur, which is the largest natural lake (289 Km2) in
eastern India, where a unique ecological condition prevails.
Phoomdi (Manipuri word meaning floating mats of soil and
vegetation) is a unique untapped habitat with heterogenous
mass of soil, vegetation and organic matter in different
stages of decay. Seven soil samples each of approximately
50 g were collected from the pristine site. Each sampling
was carried out at least 5 m apart. The samples were placed
in sterile plastic containers, which were tightly sealed and
transported to the laboratory.Culture media
Starch casein agar (SCA): Soluble starch, 10.0 g; casein,
0.3 g; KNO3, 2.0 g; NaCl, 2.0 g; K2HPO4, 2.0 g;
MgSO4.7H2O, 0.05 g; CaCO3, 0.02 g; FeSO4.7H2O,
0.01 g; Agar, 20.0 g; distilled water, 1,000 ml; pH 7.0.
Actinomycetes Isolation Agar {(AIA); HiMedia Laboratories
Pvt. Limited, Mumbai, India}: Sodium caseinate, 2.0 g;
Asparagine, 0.1 g; Sodium propionate, 4.0 g; Dipotassium
phosphate, 0.5 g; Magnesium sulphate, 0.1 g; Ferrous
sulphate, 0.001 g and Agar 20.0 g; distilled water, 1,000 ml;
pH 7.0. Glucose Soyabean meal broth (GSB) containing
Glucose, 10.0 g; Soyabean meal, 10.0 g; NaCl, 10.0 g;
CaCO3, 1.0 g; distilled water, 1,000 ml and pH adjusted to
7.0 was used as the production medium.
Test microorganisms
The test bacterial strains used for screening of antimicro-
bial activity were procured from microbial type culture
collection (MTCC) and Gene Bank of the Institute of
Microbial Technology (IMTECH), Chandigarh, India and
are: Bacillus subtilis MTCC 736, Bacillus circulans MTCC
8074, Bacillus megaterium MTCC 8075, Staphylococcus
aureus MTCC 96, Micrococcus luteus MTCC 2987, Myco-
bacterium phlei MTCC 1724, Mycobacterium smegmatis
MTCC 6, Escherichia coli MTCC 739, Klebsiela pneumo-
niae MTCC 3040, Pseudomonas aeruginosa MTCC 2453.
Apart from these one clinical isolate of Staphylococcus
aureus obtained from Down Town Hospital Ltd., Guwa-
hati, Assam, India was also used as test pathogen during
the investigation.
Isolation of the actinomycete strain
During the course of screening for antibiotics from
actinomycetes of Loktak habitats, the strain SU118
was isolated by serial dilution technique using SCA
medium [12] by incubating at 28°C for 10 days from
the soil sample collected from phoomdi in Loktak
lake of Manipur, India. The pure culture of the isolate
was obtained by repeated streaking on SCA plates.
The pure isolate was transferred to SCA slants and
preserved at 4°C for further use.
Identification of the actinomycete strain
The identification of the strain SU118 was carried out on
the basis of the cultural characteristics, morphological,
biochemical characteristics, through the courtesy of
MTCC and Gene Bank of IMTECH, Chandigarh, India
and also by the 16S rRNA gene sequencing carried out
through the courtesy of National Centre for Cell Science,
Pune, India.
Construction of phylogenetic tree
The sequenced 16S rRNA gene of the strain SU118 was
aligned with the nucleotide sequences of Streptomyces
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with more than 98% homology were considered for
molecular taxonomy analysis. Multiple alignments of 16S
rRNA nucleotide sequences in this study and sequences
from GenBank database was performed with CLUSTAL W
program [14]. A phylogenetic tree was generated using
neighbor-joining method [15] with bootstrap testing [16]
of 1,000 replicates, in MEGA6 [17].
Morphological, cultural, physiological and biochemical
characteristics
The morphological characteristics were studied by using
cover slip method in which the culture was transferred
to the base of cover slips buried in SCA medium [18]
and incubated at 28°C for seven days. The morphology of
spore bearing hyphae with entire spore chain was then
studied as described in Bergey’s manual [19]. Carbohydrate
utilization was determined by growth on carbon utilisation
medium (International Streptomyces Project 9) [20] supple-
mented with 1% carbon source at 28°C. Temperature range,
pH range and NaCl tolerance for growth was determined
on inorganic salt starch agar medium (ISP 4) by growing at
different temperatures (20–42°C), pH (5–10) and NaCl
concentration (1-5% NaCl) respectively. Hydrolysis of
starch, Liquefaction of gelatin and other biochemical tests
were evaluated by following the methods of Gordon et al.
[21]. Reduction of nitrate and production of melanoid
pigment were determined by the method of ISP [22].
Determination of LL-Diaminopimelic acid (L-DAP) and
sugar pattern were carried out according to Becker et al.
[23] and Lechevalier and Lechevalier [24]. All the results
were recorded after seven days of incubation.
Determination of antimicrobial potential of strain SU118
Spot inoculation on agar medium
The antimicrobial activity was studied primarily by spot
inoculation technique on agar medium as reported by
Singh et al. [12]. The isolate SU118 was spot inoculated
on SCA, the petri plates were incubated at 28°C for
seven days and then inverted for 40 minutes over
chloroform in fumehood. Colonies were then covered
with a 0.6% agar layer of nutrient agar (NA) previously
seeded with bacterial suspension of 1.5 × 108 colony
forming units (CFU/spores)/ml in sterile normal saline
[25] of the target bacterial strains and then incubated at
37°C for 24 h. The zone of inhibition of growth of the
test microorganisms around the actinomycete isolate
SU118 was observed after incubation. S. aureus MTCC
96 was more sensitive to the antimicrobial agent; hence
further studies were carried out with it.
Antimicrobial agent production in liquid medium
After preliminary testing for its antimicrobial potentiality,
the isolate SU118 was further studied for the productionof antimicrobial agent in liquid medium in shake flask
condition. The effect of culture media on production of
antimicrobial agent was examined by taking different
liquid media such as Starch casein broth, Actinomycetes
broth, Nutrient broth and GSB. A homogenous bacterial
suspension (0.2 O.D measure at 600 nm) of the isolate
SU118 in 0.05% Tween 20 was prepared by taking inoculum
from seven days old culture grown on SCA plate at 28°C.
Five ml of this suspension was inoculated into 100 ml of
each liquid media contained in 250 ml Erlenmeyer flask and
incubated at 28°C in a shaking incubator maintained at
150 rpm for seven days. After incubation each culture
broths were centrifuged at 10,000 × g (Sorvall Biofuge Primo
R) for 20 minutes at room temperature. The cell free
supernatants were tested for extracellular antimicrobial
activity by standard agar well diffusion method [26] against
S. aureus MTCC 96, the most sensitive test organism in
preliminary screening. Nutrient agar plates were inoculated
with 0.2 ml of overnight culture of S. aureus suspension
containing 1.5 × 108 cells as mentioned above and uni-
formly spread out with the help of sterile glass spreader.
Agar wells (6 × 4 mm) were prepared by scooping out the
medium with a sterile cork borer. The supernatant culture
broth of each medium were then administered to the wells
separately and incubated at 37°C for 24 h. Antimicrobial
activity was determined by measuring the inhibition zone
diameter (in mm) of S. aureus MTCC 96 around the well
after incubation. Each experiment was conducted in three
replicates and the mean value of inhibition zone diameter
was calculated. Uninoculated broth medium added to
the wells were taken as control. Among the different
liquid media tried, GSB was found to be the best
medium for antimicrobial agent production by the
isolate SU118; hence GSB was used as production
medium for further studies.
Effect of temperature, pH and incubation period on
growth and production of antimicrobial agent
The effect of temperature on growth and production of
antimicrobial agent was studied on GSB at different
temperatures (25, 28, 31, 34 and 37°C) at pH 7. Five ml
of spore suspension of isolate SU118 was inoculated into
100 ml of GSB contained in 250 ml Erlenmeyer flask
and incubated in a shaking incubator maintained at
150 rpm for seven days. The antimicrobial activity
was evaluated against S. aureus MTCC 96 by agar
well diffusion method in the similar manner as mentioned
above. Similarly, the effect of pH on the production of
antimicrobial agent was studied at different pH (5–9)
using GSB by incubating at 28°C for seven days. The
effect of incubation period on the production of anti-
microbial agent was also studied in the similar way as
above by incubating for different days (1–10) at 28°C
using GSB at pH 7.
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The biomass from the culture filtrate separated by means
of centrifugation was transferred to a pre-weighed dry
filter paper using a clean spatula and then placed in an
oven at 50°C overnight to reach a fixed weight. Growth in
terms of biomass accumulation was expressed as mg/ml
of culture medium.
Specific rate of product formation (qp)
The specific rate of production of the antimicrobial
agent (qp) was calculated according to the following
equation:
qp ¼ 1=X dp=dtð Þ;
Where X is the biomass concentration (mg/ml), p is
antimicrobial agent concentration and t is time respect-
ively. The derivative dp/dt was calculated according to the
method proposed by Le Duy and Zajic [27].
Extraction, purification and bioassay of the metabolite
The culture broth of the isolate SU118 grown on GSB
for 7 days at 28°C in a shaking incubator (150 rpm) was
centrifuged at 10,000 × g (Sorvall Biofuge Primo R) for
20 minutes at room temperature. The crude bioactive
metabolite produced in liquid culture medium by the
isolate SU118 was extracted from the supernatant
obtained by manual shaking thrice with equal volume of
ethyl acetate (1:1) in a separating funnel. The solvent
layer was collected and then evaporated under vacuum
in a rotary evaporator (Buchi R-114, Germany) main-
tained at 40°C water bath and the crude metabolite thus
obtained was subjected to partial purification. Purification
of this crude metabolite was carried out by thin layer chro-
matography (TLC) technique on silica gel (Merck Ltd.)
using hexane-ethyl acetate (Merck Ltd.) gradient (1:1→
1:3) as running solvent system. TLC purified fractions were
recovered and antimicrobial activity was tested by agar
well diffusion method against all the test microorgan-
isms to find out the active metabolite among the
different fractions. Each fraction was dissolved in 10%
dimethyl sulfoxide (DMSO) to get a concentration of
1 mg/ml. From this 100 μl were loaded in the agar wells
prepared on the microbial bioassay plates as mention
above. Wells filled with 10% DMSO solution served as
control. The Petri plates were incubated at 37°C for
24 h. The inhibition zone diameter against the test
microorganisms was recorded. Three replicates were
maintained in each case.
Minimum inhibitory concentration (MIC)
MIC was determined according to Boruwa et al. [28] by
adding an inoculum size of 3 × 105 colony forming units
(cfu)/ml of test microorganisms to 5 ml of nutrient brothin different test tubes. Serial dilutions of the active metab-
olite (concentration ranging from 10 μg to 0.25 μg/ml)
were added at the same time separately in the respective
tube. MIC of the active metabolite against the bacterial
test organisms was determined after 48 h of incubation by
removing 10 μl of the contents from each tube and
spreading them onto NA plates. Each set of experiment
was carried out in three replicates. Growth of the test
microorganisms were observed after 24 h of incubation at
37°C. In the similar way MIC of known antibiotic penicillin
was also carried out as a standard for comparison. MIC is
defined as the lowest concentration required to inhibit any
visible growth.
Determination of rate of kill
In vitro assays for the rate of killing bacteria by the
antimicrobial agent were carried out using a modified
plating technique of Eliopoulos and Eliopoulos [29]
and Eliopoulos and Moellering [30]. The antimicrobial
agent was incorporated into 10 ml Mueller Hinton
broth in McCartney bottles at 1/2 MIC, 1 ×MIC, and
2 ×MIC. Two controls, one Mueller Hinton broth
without the antimicrobial agent inoculated with test
organisms and Mueller Hinton broth incorporated
with the antimicrobial agent at the test concentrations
without the test organisms, were included. Inoculums
density, approximately 3 × 105 cfu/ml further verified
by total viable count, was used to inoculate 10 ml
volumes of both test and control bottles. The bottles
were incubated at 37°C on an orbital shaker at 120 rpm. A
100 μl aliquot was removed from the culture medium at
0, 4, and 8 h for the determination of cfu/ml by the plate
count technique [31] by plating out 25 μl of each of the di-
lutions. The problem of antimicrobial agent carryover was
addressed by dilution as described previously by Pankuch
et al. [32]. After incubating at 37°C for 24 h, emergent
bacterial colonies were counted, cfu/ml calculated, and
compared with the count of the culture control without
the antimicrobial agent. Each experiment was performed
in duplicate and mean value obtained. The results were
expressed as negative or positive log10 values according to
Baltch et al. [33].
Statistical analysis
Statistical analysis was carried out by calculating the
means and standard deviations of the results. Duncans
multiple range test (DMRT) was done to compare that
the sample means were significantly different from each
other at a significant level of P >0.001 [34].
Results
Characterization and taxonomy of the strain
The actinomycetes strain SU118 isolated from soil
samples of phoomdi in Loktak Lake of Manipur, India
Table 1 Morphological, physiological and biochemical




Sporophore morphology Rectus- Flexibilis (RF)
Aerial mycelium colour Light gray
Substrate mycelium colour Cream-light brown
Physiological characteristics
Growth under anaerobic condition - ve
Acid-fast reaction - ve
Production of melanoid pigment + ve
Temperature range for growth 25 – 40°C
Optimum temperature for growth 28°C
pH range for growth 5 - 9
Optimum pH for growth 7
Growth on Mc Conkey agar - ve
NaCl tolerance 3%
Biochemical characteristics
Gram reaction + ve
Catalase production - ve
Oxidase production - ve
Urease production - ve
Hydrogen sulfide production - ve
Nitrate reduction - ve
Gelatin liquefaction - ve
Methyl red test - ve
Vogues proskauer test - ve
Indole production test - ve
Citrate utilization test - ve
Starch hydrolysis + ve













Cell-wall amino acids LL-Diaminopimelic aid
Cell-wall sugars No diagnostic
Note: + ve: Positive for the test; − ve: Negative for the test.
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tive mycelium showed cream-light brown colour while
the aerial mycelium showed light gray colour. The
culture, when examined by light microscope (100 ×)
have straight to flexuous sporophores arising from the
aerial mycelium and may be placed in the Rectus-
Flexibilis (RF) group of Streptomyces species [35]. The
strain SU118 could grow up to 40°C and pH 9 with
3% NaCl concentration. LL-diaminopimelic acid (L-DAP)
was present in the cell wall but no characteristic sugar.
The strain SU118 could utilize glucose, arabinose, manni-
tol, xylose, meso-inositol, raffinose, rhamnose, salicin, su-
crose, galactose and fructose as the carbon source without
the production of acid. The morphological, physiological
and biochemical characteristics of the strain SU118 is
shown in Table 1. The 16S rRNA gene sequence of the
strain SU118 was compared with the nucleotide
sequences of other Streptomyces strains from the NCBI
GenBank database. The phylogenetic tree generated
on the basis of 16S rRNA gene sequence of the strain
SU118 and the nucleotide sequences from closely related
Streptomyces strains using neighbor-joining method is
presented in Figure 1. The strain has got maximum 16S
rRNA gene sequence homology (99%) with S. sannanensis
strain HBUM174756. Therefore, on the basis of morpho-
logical, physiological, biochemical and analysis of the 16S
rRNA gene sequence, the new isolate SU118 was desig-
nated as S. sannanensis strain SU118. The 16S rRNA gene
partial sequence of the isolate SU118 has been deposited
in the GenBank database under the accession number
EU278596. The phylogenetic tree of the strain SU118
has been deposited in TreeBASE repository with the
submission ID 16506. Further the information associated
with the phylogenetic placement of the strain SU118 is
available in http://treebase.org/treebase-web/search/study/
summary.html?id=16506. The identity of the isolate was
further confirmed by the Microbial Type Culture Collec-
tion and Gene Bank (MTCC) of the Institute of Microbial
Technology, Chandigarh, India. The culture has been
deposited in MTCC, an International Depository Authority
and the accorded accession number is MTCC-7041.
Antimicrobial potential of the strain SU118
During the course of screening of actinomycetes possessing
antimicrobial activity, it was observed that S. sannanensis
SU118 was highly antagonist to Gram-positive bacteria
including one clinical isolate of S. aureus while it does
not have any inhibitory effect against any of the tested
Gram-negative bacteria (Table 2). S. aureus MTCC 96 was
the most sensitive to the antimicrobial agent; hence it was
taken as test organism for further studies. Among the
different liquid media studied for antimicrobial agent
production in shake flask condition, GSB was found
to be most suitable for growth as well as synthesis of
Figure 1 Phylogenetic tree based on 16S rRNA gene sequences from the strain SU118 and other Streptomyces species.
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was observed that the culture filtrate of S. sannanensis
SU118 grown on GSB exhibited maximum inhibition zone
diameter against S. aureus MTCC 96 followed by the
culture filtrate grown on SC broth, while lowest activity
was seen with the one grown on NB.
Effect of cultural parameters on growth and production
of antimicrobial agent
The environmental requirements and cultural conditions
for growth and production of antimicrobial agent by
S. sannanensis SU118 has been studied on GSB in
shake flask condition. The strain S. sannanensis SU118
showed a narrow range of incubation temperature forrelatively good growth and antibiotic production. 28°C
was found to be optimum for highest growth as well as
maximum antimicrobial agent production by the strain
(Figure 3). In terms of its optimum temperature for
growth, the organism appeared to be mesophilic in nature.
The highest growth as well as maximum antimicrobial
agent production was obtained at pH 7. Poor growth was
evident at pH values below and above neutral (Figure 4).
Incubation period up to seven days was found to be
optimum for maximum growth as well as antimicrobial
agent production by S. sannanensis SU118 (Figure 5).
The highest value of specific rate of production of the
antimicrobial agent (0.0046 day −1) was observed on
6th day (Figure 6).
Table 2 Inhibition zone diameter and minimum inhibitory concentration of the active compound (Rf value 0.56)
produced by Streptomyces sannanensis SU118
Test microorganisms Inhibition zone diameter (mm) ¥ MIC (μg/ml) MIC of penicillin (μg/ml)
Bacillus subtilis MTCC 736 25 ± 1.0 2.0 0.5
Bacillus circulans MTCC 8074 23 ± 1.2 3.0 0.5
Bacillus megaterium MTCC 8075 26 ± 1.5 2.0 0.5
Staphylococcus aureus MTCC 96 31 ± 0.9 0.5 0.25
Staphylococcus aureus (Clinical isolate) 30 ± 0.9 0.5 0.25
Micrococcus luteus MTCC 2987 25 ± 1.3 2.0 0.5
Mycobacterium phlei MTCC 1724 25 ± 1.0 2.0 0.5
Mycobacterium smegmatis MTCC 6 21 ± 0.5 3.0 1.0
Escherichia coli MTCC 739 ND ND
Klebsiela pneumoniae MTCC 3040 ND ND
Pseudomonas aeruginosa MTCC 2453 ND ND
Note: Data express as mean ± SD (n =3) “ – ” : No Inhibition Zone; ¥ Concentration of the active compound: 1 mg/ml; ND – Not determined.
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http://www.biomedcentral.com/1471-2180/14/278Purification and bioactivity of the metabolite
The dark brown colored crude metabolite recovered by
solvent extraction method using ethyl acetate was purified
by TLC in a running solvent system of hexane and ethyl
acetate in 1:3 ratio. Four fractions designated as A, B, C
and D (Figure 7) with different Rf values recovered from
TLC plates were dissolved in 10% DMSO and bioassayed
against the test microorganisms. The fraction B with Rf
value 0.56 and UV λmax 275.0 nm in ethyl acetate exhibits
antimicrobial activity against all the Gram-positive
bacteria tested while it does not affect Gram-negative
bacteria (Table 2). Other fractions (A, C and D) did
not show any activity against the test organisms. Hence
the fraction B is considered as the active metabolite. The
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Figure 2 Effect of various culture media on growth and antimicrobial
(SCB- Starch casein broth; AB- Actinomycete broth; NB- Nutrient brotsensitive while M. smegmatis MTCC 6 was found to be
least sensitive to the active metabolite obtained from S.
sannanensis strain SU118. The quantitative efficacy of the
active metabolite was estimated as MIC and it has got
lowest MIC (0.5 μg/ml) against S. aureus MTCC 96 and S.
aureus (Clinical isolate), whereas highest (3.0 μg/ml) was
recorded against M. smegmatis MTCC 6 and B. circulans
MTCC 8074 (Table 2). The active metabolite was soluble
in ethyl acetate, hexane, chloroform and DMSO whereas
sparingly soluble in water.
Determination of rate of kill
The results of time-kill assay are presented in Table 3.
Data are presented in terms of the log10 cfu/ml change
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Figure 3 Effect of incubation temperature on growth and antimicrobial agent production by Streptomyces sannanensis SU118.
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http://www.biomedcentral.com/1471-2180/14/278standard, that is, a 3 log10 cfu/ml or greater reduction in
the viable colony count relative to the initial inoculums ac-
cording to Pankey and Sabath [36]. After 4 h of incubating
the bacteria with the 1 ×MICs and 2 ×MICs, the average
log reduction in the viable cell count ranged between 0.198
log10 and 1.218 log10 cfu/ml. After 8 h of incubation with
these different concentrations, the average log reduction in
the viable cell count ranged between −2.075 log10 and
0.891 log10 cfu/ml. The incubation of the bacteria for 4 h
at 1 ×MICs resulted in the average log reduction of the
viable cell count ranging between 0.959 log10 and 1.218
log10 cfu/ml, while after 8 h of incubation, the average
log reduction ranged between 0.367 log10 and 0.891
log10 cfu/ml. The incubation of the bacteria for 4 h
at 2 ×MICs resulted in the average log reduction of
the viable cell count ranging between 0.198 log10 and
0.487 log10 cfu/ml, while after 8 h of incubation, the























Figure 4 Effect of pH on growth and antimicrobial agent productionbetween −2.075 log10 and −1.484 log10 cfu/ml. The greatest
log reduction in cell density with the antimicrobial agent
was observed in S. aureus MTCC 96 (−2.075 log10 cfu/ml)
followed by S. aureus (Clinical isolate) (−1.953 log10 cfu/ml),
while least log reduction in cell density was observed in
M. smegmatis MTCC 6 (−1.484 log10 cfu/ml).
Discussion
Actinomycetes have been recognized as the potential
producers of metabolites such as antibiotics, growth
promoting substances for plants and animals, immunomo-
difiers, enzyme inhibitors and many other compounds of
use to man. Isolation of new microbial species from hith-
erto unexplored areas and/or from extreme environments
is one of the more efficient approaches for the develop-
ment of potential novel bioactive metabolites [37,38]. The
high proportion of strains producing antimicrobials from
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Figure 5 Effect of incubation period on growth and antimicrobial agent production by Streptomyces sannanensis SU118.
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http://www.biomedcentral.com/1471-2180/14/278aggressive roles of the organisms for maintaining their
ecological niche in such environments. Further, the
thriving of microorganisms in such competitive envi-
ronments is assumed that their metabolic compatibil-
ity is strongly influenced by natural selection [39].
With this perspective, an antimicrobial agent producing
actinomycete strain SU118 was isolated from the phoomdi
soil of Loktak lake in Manipur, India. The isolate has been
characterized and identified as S. sannanensis strain
SU118.
The antimicrobial activity of S. sannanensis SU118 was
screened against various Gram-positive and Gram-negative
organisms. The results showed that S. sannanensis SU118Figure 6 Specific rate of antimicrobial agent production (qp) by Strepsecretes a narrow spectrum antimicrobial agent which
could inhibit the growth of only Gram-positive bacteria.
However, it did not affect the growth of Gram-negative
organisms. Similar antimicrobial activity specific to
Gram-positive bacteria has also been reported in S.
aburaviensis strain Kut-8 [40]. The reason for differential
sensitivity between Gram-positive and Gram-negative bac-
teria could be ascribed to the morphological differences
between these microorganisms; Gram-negative bacteria
have an outer polysaccharide membrane carrying the
structural lipopolysaccharide components. This makes
the cell wall impermeable to lipophilic compounds;
the Gram-positive bacteria, on the other hand, will betomyces sannanensis SU118.
Figure 7 Thin layer chromatography plate showing the separation of bioactive compound (fraction B) obtained from Streptomyces
sannanensis SU118.
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Table 3 In vitro time-kill assessment of the antimicrobial agent against the test microorganisms
Test bacterial strains Log10 Kill Log10 Kill Log10 Kill
(½) X MIC MIC 2 X MIC
0 h 4 h 8 h 0 h 4 h 8 h 0 h 4 h 8 h
Bacillus subtilis MTCC 736 2.381 3.131 4.213 2.364 1.165 0.507 2.286 0.365 −1.776
Bacillus circulans MTCC 8074 2.456 3.233 4.336 2.478 1.213 0.578 2.346 0.389 −1.501
Bacillus megaterium MTCC 8075 2.234 3.691 4.821 2.227 1.186 0.515 2.242 0.296 −1.875
Staphylococcus aureus MTCC 96 2.487 2.756 3.251 2.491 0.959 0.367 2.475 0.198 −2.075
Staphylococcus aureus (Clinical isolate) 2.983 3.423 4.206 2.907 0.979 0.406 2.915 0.203 −1.953
Micrococcus luteus MTCC 2987 2.169 2.792 3.042 2.127 1.146 0.723 2.217 0.401 −1.637
Mycobacterium phlei MTCC 1724 2.291 2.813 3.112 2.251 1.187 0.811 2.252 0.431 −1.576
Mycobacterium smegmatis MTCC 6 2.386 2.912 3.102 2.298 1.218 0.891 2.379 0.487 −1.484
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layer which is not an effective permeability barrier [41].
The study on the production of antimicrobial agent
usually involves a search of a suitable culture medium.
Among the four media tried, GSB was found to be the
optimum medium for antimicrobial agent production by
S. sannanensis SU118. It was evident from the finding that
the antimicrobial agent production by S. sannanensis
SU118 was positively affected by the nature and type of
carbon and nitrogen sources in the medium. The results
showed that antimicrobial agent production was higher in
medium having glucose and soyabean meal as carbon and
nitrogen source respectively. This result is quite comparable
with S. griseocarneus, for which glucose was found to be
suitable carbon source for the antibiotic production [42].
Considering the carbon source, simple sugar such as
glucose, fructose, sucrose as sole carbon source enhanced
growth as well as bioactive metabolite production rather
than more complex carbons [43]. Our result is also in
conformity with the findings of Singh et al. [7] for
which soyabean meal proved to be suitable carbon
source for antibiotic production by S. tanashiensis A2D.
The results indicated the dependence of the antimicrobial
agent synthesis on the medium constituents. In fact, it has
been shown that the nature of carbon and nitrogen
sources strongly affect antibiotic production in different
organisms [44]. The strain S. sannanensis SU118 showed
a narrow range of incubation temperature for relatively
good growth and antimicrobial agent production. Highest
growth and antimicrobial agent production was obtained
at 28°C. The temperature range adequate for good
production of secondary metabolites is narrow, for
example, 5 ~ 10 degrees [45]. The maximum growth
as well as highest antimicrobial activity by S. sannanensis
SU118 was achieved at pH 7 while it does not exhibit any
activity at pH 9. There are reports regarding the role of pH
on the production of bioactive metabolite by microorgan-
isms [46]. Incubation period upto seven days was found to
be optimum for highest antimicrobial agent production bythe strain SU118. Griffiths and Saker [47] reported
that maximum secretion of bioactive metabolites by
Cylindrospermopsis raciboskii was found to occur as
cultures moved into the post-exponential phase of
growth, while Egorov [48] postulated that maximum
antimicrobial activity was attained after reaching the
maximum value of the biomass. The results indicated
that environmental factors and cultural conditions like
incubation temperature, pH and incubation period were
found to have profound influence on antimicrobial agent
production by S. sannanensis SU118 as surveyed in
streptomycetes by other investigator [49]. The result
for the determination of specific rate of production of
antimicrobial agent by the strain SU118 showed to be
maximum on the sixth day (0.0046 day −1). The strain
SU118 showed specific potential in antimicrobial agent
production. Other observations on the specific rate
of production of bioactive metabolite by different
microorganism have also been reported [50,51].
The solvent extraction of the culture broth of S.
sannanensis SU118 using ethyl acetate and subsequent
purification led to the recovery of a potent antibacterial
agent active against Gram-positive bacteria. Remya and
Vijaykumar [52] have reported the antimicrobial potential
of compound obtained from ethyl acetate extract of
Streptomyces strain RM42. Similarly, the extraction of
antibiotics has been carried out from streptomycetes
by using various solvents including ethyl acetate and
methanol [53,54].
The resultant effect of incubating the bacteria at 2 ×MICs
was a significantly rapid reduction in the average log of the
viable cells counts. This reduction is greater than the rate of
kill observed in the test bacterial strains treated with the
1×MICs. The significant reduction in the cell counts
between 4 and 8 h of incubation period acknowledged the
fact that the antimicrobial agent was highly bactericidal
seeing that the bacterial colonies were almost totally wiped
out after incubating for 8 h. On the contrary, there was a
net growth of all the test bacterial strains treated with the
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ition and efficacy of the antimicrobial agent were observed
to be concentration and time dependent producing distinct
time-kill profiles for the tested bacterial strains.
Detection and identification of members of the genus
Streptomyces are of great value because they provide a
rich source of antibiotics. The emergence and dissemin-
ation of antibacterial resistance is well documented as a
serious problem worldwide [55]. Smith et al. express
that “The emergence of bacterial resistance threatens
to return us to the era before the development of
antibiotics” [56]. The perspective of rapid emergence of
drug resistance among bacterial pathogens shows that
the potencies of prevalent antibiotics are decreasing
steadily, leading to reduced useful-period of drugs. This
situation compounds the need for the investigation of
new, safe and effective antimicrobials for replacement
with invalidated antimicrobials or use in antibiotic rotation
programs [57].Conclusions
The strain SU118 showed a narrow spectrum of activity
inhibiting only Gram-positive bacteria, when tested
with crude culture filtrate and also with active metabolite
(Rf value = 0.56). The MICs of the antimicrobial agent
against the test pathogens indicated the potent activity
which highlights its prospective and could be a candidate
in the generation of new antimicrobial agents and
also throws a light towards the fight against drug re-
sistant pathogens especially of the methicillin resistant
Staphylococcus aureus (MRSA), since this particular
isolate SU118 inhibits only the Gram positive bacteria.
The findings of the present study showed that naturally
occurring actinomycetes have a great potential to produce
metabolite active against bacteria enabling discovery of
new antibiotics and hence merit future studies. Further
ongoing detailed characterization and structure elucidation
of the bioactive metabolite may be a new entity reported
from this unique untapped ecological niche.
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